Editorial Board

Editor-in-Chief
Yun-Fai Chris Lau, PhD, University of California, San Francisco, USA
Dr Lau is a Professor at the University of California, San Francisco, and a Research Career Scientist of the San Francisco VA Health Care System. After serving as a founding Associate Editor of the Editorial Board, he has been appointed as the Editor-in-Chief of Cell & Bioscience, effective January 1, 2020. Dr Lau received his B.A. in Chemistry from the Harpur College at the Binghamton University in 1973, and his M.Sc. in 1976 and Ph.D. in 1979 in Cell Biology from the M.D. Anderson-UT Health Graduate School of Biomedical Science at Houston, Texas. He received additional postdoctoral training under an AP Giannini fellowship at the University of California, San Francisco from 1979-84 and was involved in the early technology development in whole genome recombinant DNA library constructions. In 1984, he became a faculty member of the Department of Medicine.  Dr Lau is interested in understanding the functions of genes on the male-specific Y chromosome and their X-homologues in sex determination and sex differences in human diseases and cancers, using molecular genetics, genomics and transgenic strategies. Dr Lau has mentored numerous undergraduate and graduate students, postdoctoral fellows and junior faculty members throughout his academic career.  He has published over 140 research articles, scientific reviews and book chapters and edited two books in his fields.

Associate Editor-in-Chief
Dong-Yan Jin, DMedSc, The University of Hong Kong, Hong Kong
Prof Dong-Yan Jin did his PhD study with Prof. Yun-De Hou at the State Key Laboratory for Molecular Virology in Beijing in 1986-1991. He received postdoctoral training with Dr. Kuan-Teh Jeang at the NIAID, NIH in 1994-1999. He joined the University of Hong Kong in 1999 and is now Clare and Lawrence Fok Professor in Precision Medicine. He is molecular virologist with an interest on viral oncogenesis and innate antiviral response. In his study of a viral oncoprotein named Tax produced by human T-cell leukemia virus type 1, which causes a highly lethal blood cancer known as adult T-cell leukemia, he identified in 1998 a cellular protein named MAD1, a key component of the mitotic checkpoint. In 2011, his group found that the virus sensor RIG-I needs an RNA-binding protein partner called PACT to initiate and sustain innate antiviral response. They have also identified and characterized novel viral interferon antagonists and inflammasome activators in SARS-CoV, MERS-CoV and SARS-CoV-2. Many of their findings have not only broken new grounds to understand virus-host interaction and viral pathogenesis, but also revealed new strategies and leads for disease prevention and intervention.

Lin Mei, PhD, Chinese Institutes for Medical Research, China
Dr. Lin Mei: Dr.  Mei is Professor and Chair, Department of Neurosciences; Allen C. Holmes Professor; and Director, Cleveland Brain Health Initiative, Case Western Reserve University School of Medicine, Cleveland, Ohio. Dr. Mei graduated from Jiangxi Medical College, Nanchang University. After earning PhD in Pharmacology and Toxicology at University of Arizona, he went to Johns Hopkins University School of Medicine for postdoctoral training. He was on faculty at University of Virginia; University of Alabama at Birmingham; and Medical College of Georgia, Augusta University. Dr. Mei is interested in synapse formation and plasticity. His lab has revealed molecular mechanisms of the assembly and maintenance of the neuromuscular junction and identified biomarkers such anti-LRP4 antibodies for diagnosis of neuromuscular disorders. In addition, Dr. Mei and his colleagues have uncovered physiological functions and pathological mechanisms of genes that are implicated in brain disorders including schizophrenia, autism, and major depression. They found that the neuregulin 1-ErbB4 signaling is critical to homeostasis of brain activity.

Ying E. Zhang, PhD, National Institutes of Health, USA
Dr Ying E Zhang is a Senior Investigator of the Center for Cancer Research at the National Cancer Institute, National Institutes of Health. Dr. Zhang received her B.A. in Chemistry and M.Sc. in Biochemistry from Peking University, Beijing, China, and her Ph.D. in Biomolecular Chemistry from the University of Wisconsin-Madison. She performed her postdoctoral studies in the Dr. Rik Derynck’s laboratory at the University of California, San Francisco from 1995-2000 and was involved in the identification and characterization of SMAD proteins and their role in TGF-beta signaling. In 2000, she joined the National Cancer Institute, National Institutes of Health to continue her research in TGF-beta signaling using a combination of biochemical, genomic and and mouse genetic approaches.  Discoveries from her research generated mechanistic insight into how TGF-beta controls cell-context dependent cellular responses through SMAD-dependent and -independent pathways during development, tissue homeostasis and tumorigenesis.

Founding Editor-in-Chief
Yun-Bo Shi, PhD, National Institutes of Health, USA

Founding Editor
Kuan-Teh Jeang, MD, PhD, National Institutes of Health [deceased 2013]

Editors
Jia Chen, ScD, Icahn School of Medicine at Mount Sinai, USA
Wanjun Chen, MD, OIIB, NIDCR, National Institutes of Health, USA
Xin Chen, PhD, University of Hawaii Cancer Center, USA
Wen-Xing Ding, PhD, The University of Kansas, USA
Zhong-Ping Feng, MD, PhD, University of Toronto, Canada
Zhe Han, PhD, University of Maryland School of Medicine, USA
Wanjin Hong, PhD, Institute of Molecular and Cell Biology, Singapore
Jim Hu, PhD, University of Toronto, Canada
Peng Jin, PhD, Emory University, USA
Tianru Jin, PhD, University of Toronto, Canada
Wansheng Liu, PhD, The Pennsylvania State University, USA
Kwok Wai Lo, PhD, Chinese University of Hong Kong, Hong Kong
Kunxin Luo, PhD, University of California-Berkeley, USA
Zhiping P Pang, MD, PhD, Rutgers University, USA
Duanqing Pei, PhD, Westlake University, China
Yun Qui, PhD, University of Maryland School of Medicine, USA
Yufang Shi, PhD, Soochow University, Suzhou, China
Stephen H Tsang, MD, PhD, Columbia University, USA
Yu-Jui Yvonne Wan, PhD, University of California-Davis, USA
Xin Wei Wang, PhD, NCI, National Institutes of Health, USA
Lixin Wei, PhD, Second Military Medical University, China
Long-Jun Wu, PhD, University of Texas Health Science Center, USA
T-C Wu, MD, PhD, The Johns Hopkins University, USA
Xiaolei Xu, PhD, Mayo Clinic, USA
Yong Xu, MD, PhD, Baylor College of Medicine, USA
Dongmin Yin, MD, PhD, East China Normal University, China
Zhi-Ming Zheng, MD, PhD, NCI, National Institutes of Health, USA
Huiping Zhou, PhD, Virginia Commonwealth University, USA
Dr Rongjia Zhou, PhD, Wuhan University, China

Senior Editorial Advisors
Chuxia Deng, PhD, University of Macau, China
Mengfeng Li, MD, PhD, Southern Medical University, China
Paul Liu, MD, PhD, NHGRI, National Institutes of Health, USA
Yang Shi, PhD, Oxford University, UK
Sophia Tsai, PhD, Baylor College of Medicine, USA
Xiao-Fan Wang, PhD, Duke University Medical Center, USA
Wei Yang, PhD, NIDDK, National Institutes of Health, USA
Yingzi Yang, PhD, Harvard School of Dental Medicine, USA
Dihua Yu, MD, PhD, The University of Texas M.D. Anderson Cancer Center, USA
Keji Zhao, PhD, NHLBI, National Institutes of Health, USA

Editorial Board
Wai-Yee Chan, PhD, The Chinese University of Hong Kong, Hong Kong
Pei Jer Chen, MD, PhD, National Taiwan University, Taiwan
Sai-Juan Chen, DSc, Shanghai Jiao Tong University School of Medicine, China
Mei-Ru Chen, PhD, National Taiwan University, Taiwan
Martin Chi-Hang Cheung, PhD, The University of Hong Kong, Hong Kong
Ya-Hui Chi, PhD, National Health Research Institutes, Taiwan
Mary Dasso, PhD, NICHD, National Institutes of Health, USA
Elia Duh, MD, Johns Hopkins University School of Medicine, USA
Xin-Hua Feng, PhD, Zhejiang University, China
Adrien Guillot, PhD, Charité - Universitätsmedizin Berlin, Germany
Peixuan Guo, PhD, Ohio State University, USA
Jing Huang, PhD, NCI, National Institutes of Health, USA
Ralf Jauch, PhD, The University of Hong Kong, Hong Kong
Hung-Ying Kao, PhD, Case Western Reserve University, USA
Juliann Kiang, PhD, Uniformed Services University of the Health Sciences, USA
A-N Tony Kong, PhD, Rutgers - The State University of New Jersey, USA
James Yuanhao Li, PhD, University of Connecticut, USA
Ming-Fong Lin, PhD, University of Nebraska Medical Center, USA
Kun Ping Lu, MD, PhD, Western University, Canada
Ji Luo, PhD, National Institutes of Health, USA
Stephanie Kwai Yee Ma, PhD, The University of Hong Kong, Hong Kong
Daiwen Pang, PhD, Wuhan University, China
Michelina Plateroti, PhD, Institute of Genetics and Molecular and Cellular Biology (IGBMC), France
Zhaohui Qian, PhD, Chinese Academy of Medical Sciences & Peking Union Medical College, China
Mai Har Sham, PhD, Chinese University of Hong Kong, Hong Kong
Zhiyuan Shen, MD, PhD, Rutgers Cancer Institute of New Jersey, USA
Shijie Sheng, PhD, Wayne State University School of Medicine, USA
Rio Sigamura, MD, PhD, The University of Hong Kong, Hong Kong
Tse-Hua Tan, PhD, National Health Research Institutes, Taiwan
Yanmei Tao, PhD, Southeast University, China
Zhou Wang, MD, PhD, University of Pittsburgh, USA
Wei-Zen Wei, PhD, Wayne State University, USA
Jiemin Weng, PhD, East China Normal University, China
Chi Ming Wong, PhD, The Polytechnic University of Hong Kong, Hong Kong
Joseph K Wong, MD, University of California, San Francisco, USA
Patrick CY Woo, MD, National Chung Hsing University, Taiwan
Ji Wu, PhD, Shanghai Jiao Tong University, China
Gutian Xiao, PhD, University of Southern California, USA
Ting Xie, PhD, Hong Kong University of of Science and Technology, Hong Kong
Jianming Xu, PhD, Baylor College of Medicine, USA
Xuehong Xu, PhD, Shaanxi Normal University, China
Hua Yu, PhD, Beckman Research Institute of City of Hope, USA
Baojun Zhang, PhD, Xi-an Jiaotong University, China
Li Zhang, PhD, The University of Texas at Dallas, USA
Hui Zhao,  PhD, The Chinese University of Hong Kong, Hong Kong
Mu-Sheng Zheng, MD, PhD, Sun Yat-sen University Cancer Center, China
Richard Y Zhao, PhD, University of Maryland School of Medicine, USA
Renping Zhou, PhD, Rutgers College of Pharmacy, USA